Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed)
The Catalyze Product Definition Funding Opportunity Announcement (FOA) offers early-stage financial support for the development and testing of medical device prototypes, identification of disease targets for diagnostics, and creation of research tools to treat heart, lung, blood, and sleep (HLBS) disorders, with the goal of advancing these projects to a stage where they can qualify for the NHLBI Catalyze Preclinical program or secure further development funding from other sources.
$250,000
Closed
Nationwide
Key Dates
Next Deadline
October 21, 2024
Letter of Intent
Application Opens
January 24, 2022
Application Closes
November 21, 2024
Contact Information
Grantor
NIH OER Webmaster
Subscribe to view contact details
Newsletter Required
Categories
Health
